Literature DB >> 26926583

Platelet Function Tests.

Marie Lordkipanidzé1.   

Abstract

Traditionally developed for diagnosis of bleeding disorders, platelet function assays have become increasingly used in basic research on platelet physiology, in phenotype-genotype associations in bleeding disorders, in drug development as surrogate endpoints of efficacy of new antiplatelet therapy, and to an extent, in the monitoring of antiplatelet therapy in clinical practice to predict thrombotic and bleeding risk. A multiplicity of platelet function assays is available to measure the level of platelet activity in various settings. These include assays that are restricted to a specialized laboratory as well as point-of-care instruments meant to investigate platelet function at patient bedside. Unlike tests that determine a defined quantity or measurement of a clinical biomarker (e.g., cholesterol or blood pressure), platelet function testing assesses the dynamics of living cells, which immediately presents a series of unique problems to any laboratory or clinic. This article presents currently used platelet function assays and discusses important variables to take into account when performing these assays, including preanalytical issues and difficulties in interpreting platelet function test results. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926583     DOI: 10.1055/s-0035-1564834

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

1.  Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial.

Authors:  Nathan Messas; Jean-François Tanguay; Marie Lordkipanidzé
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Utility of platelet function testing in stent-assisted coiling of cerebral aneurysms.

Authors:  Mirja M Wirtz; Clemens M Schirmer; Oded Goren; Christian O Bohan; Shamsher Dalal; Gregory Weiner; Paul M Foreman; Christoph J Griessenauer
Journal:  Interv Neuroradiol       Date:  2019-12-19       Impact factor: 1.610

Review 3.  The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review.

Authors:  Soloman Saleh; Jacob George; Katharine A Kott; Peter J Meikle; Gemma A Figtree
Journal:  Front Cardiovasc Med       Date:  2022-06-02

4.  Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Marianne E Nellis; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Adam M Vogel; Gemma Crighton; Stacey L Valentine; Meghan Delaney; Robert I Parker
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

5.  Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition-Insights for Multi-Center Trials.

Authors:  Jean-Christophe Bélanger; Fabio Luiz Bandeira Ferreira; Mélanie Welman; Rahma Boulahya; Jean-François Tanguay; Derek Y F So; Marie Lordkipanidzé
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

Review 6.  Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Authors:  Georges Jourdi; Anne Godier; Marie Lordkipanidzé; Guillaume Marquis-Gravel; Pascale Gaussem
Journal:  Front Cardiovasc Med       Date:  2022-01-28

7.  Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy.

Authors:  Chun Yin; Yanhui Wang; Chunhua Mo; Zong Yue; Yihong Sun; Dayi Hu
Journal:  BMC Cardiovasc Disord       Date:  2022-03-04       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.